Skip to content

GLW Announces FDA 510(K) Clearance for the Artemis Proximal Femoral Nail System

By admin

A FOURTH-GENERATION HIP FRACTURE NAIL MANUFACTURED USING A REVOLUTIONARY PROCESS ENGLEWOOD CLIFFS, NJ, USA, February 22, 2021 / – GLW Trauma, a GLW Medical Innovation (GLW) company announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Artemis Proximal Femoral Nail System (the “Artemis System”), a hip fracture … Continued

GLW Receives FDA 510(k) Clearance for the Creed™ Cannulated Screw System

By admin

ENGLEWOOD CLIFFS, NJ, USA, December 17, 2020 — GLW Foot & Ankle (Carbon22), a GLW Medical Innovation Company, announced today that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) to market the Creed™ Cannulated Screw System, a portfolio of unique, see-through “ortholucent” bone screws used for foot and ankle surgery. … Continued

GLW Receives FDA 510(k) Clearance for FusionFrame™ Ring Lock System

By admin

Carbon22 Consortium designed circular external fixator can treat complex foot and ankle deformities as well as provide a static frame for various indications. ENGLEWOOD CLIFFS, NJ, USA, September 29, 2020 — GLW Foot & Ankle (Carbon22), a GLW Medical Innovation company announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration … Continued